Increased T cell activation in BALF from children with Mycoplasma pneumoniae pneumonia

Li Guo1, Fang Liu2,3, Mei-Ping Lu1,2

  • 1Department of Rheumatology Immunology & Allergy, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.

Pediatric Pulmonology
|August 27, 2014
PubMed
Abstract

Insights

Activated T cells in the airways contribute to lung inflammation in severe Mycoplasma pneumoniae pneumonia (MPP). Elevated IL-6 levels may indicate disease severity and prognosis in pediatric MPP patients.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Pediatric Infectious Diseases

Background:

  • The precise mechanisms driving Mycoplasma pneumoniae-induced lung inflammation remain incompletely understood.
  • Investigating the role of airway-activated T cells in severe Mycoplasma pneumoniae pneumonia (MPP) is crucial for understanding disease pathogenesis.

Purpose of the Study:

  • To determine if activated T cells in the airway contribute to pulmonary inflammation in children with severe MPP.
  • To explore the correlation between T cell activation markers, inflammatory cytokines, and disease severity in MPP.

Main Methods:

  • Bronchoalveolar lavage fluid (BALF) was collected from 45 children with MPP (mild and severe), 20 severe cases at recovery, and 20 controls with foreign body aspiration.
  • Flow cytometry was used to analyze CD3+ T cells and their activation markers (CD69+, HLA-DR+, CD25+).
  • ELISA measured IL-6 and IL-10 levels, and neutrophil percentages were quantified.

Main Results:

  • Children with MPP showed increased neutrophils, IL-6, IL-10, and activated T cells (CD69+, HLA-DR+, CD25+) compared to controls.
  • Severe MPP cases exhibited higher neutrophils, CD3+ CD25+ T cells, IL-6, and IL-10 than mild cases.
  • During recovery from severe MPP, T cell percentages increased, while neutrophils and IL-6 decreased, with reduced CD69+ and CD25+ expression on T cells.

Conclusions:

  • Activated T cells in BALF are implicated in the inflammatory response during acute and severe MPP.
  • Interleukin-6 (IL-6) may serve as a predictive marker for MPP severity and patient prognosis.
  • Further research is needed to elucidate the detailed underlying mechanisms of T cell involvement in MPP pathogenesis.